Venezuelan-based residential and business network provider upgrades MikroTik with OcNOS for enhanced Edge and Aggregation Routing
SANTA CLARA, Calif., May 14, 2024 – IP Infusion, a global leader in open networking solutions, today announced that Venezuelan-based network service provider Netcom Plus has deployed IP Infusion software products with hardware from Edgecore e UfiSpace to upgrade its backbone network to accommodate modern bandwidth and new features. This deployment is a significant upgrade to an existing MikroTik installation, a configuration that could no longer accommodate current service demands or growth.
Netcom Plus ha valutato diverse opzioni di aggiornamento da vendor come Cisco, SONiC e Cumulus. Sebbene il costo fosse un fattore significativo, alle altre soluzioni mancavano anche le funzionalità Service Provider avanzate richieste da Netcom Plus: tunnel VPLS, funzionalità Layer 2, BGP e routing OSPF. In addition, by deploying OcNOS on Edgecore and UfiSpace networking hardware, Netcom Plus was able to dramatically increase bandwidth capacity, from 10-20 Gbps to an upper capacity of 2.4Tbps.
"It was clear the IP Infusion solution beat out the competition on features alone. When you factor in cost, the choice was obvious," said Hugo Araujo, CTO for Netcom Plus. "MikroTik is old hardware and software, old processors. OcNOS feels like driving a new car, and the upgrade was plug-and-play directly through IP Infusion."
"The service provider market will always be important to IP Infusion," said Atsushi Ogata, President and CEO of IP Infusion. "Because we work closely with our top-tier client partners, listening to their needs, and providing tailored, cost-effective solutions, we have become the premier one-stop shop for the complete networking needs of any organization."
Chi è IP Infusion
IP Infusion manufactures open network software and solutions for carriers, service providers, and data centers. With hundreds of customers and thousands of deployments, IP Infusion is a market leader in Network Operating Systems. Our flagship software platform OcNOS® allows network operators to disaggregate their networks, streamline operations, and reduce Total Cost of Ownership (TCO). Network OEMs can also disaggregate network devices to expedite time to market, offer comprehensive services, and achieve carrier-grade robustness.
IP Infusion is headquartered in Santa Clara, Calif., and is a wholly owned and independently operated subsidiary of ACCESS CO., LTD. Additional information can be found at http://www.IPInfusion.com.
IP Infusion and OcNOS are trademarks or registered trademarks of IP Infusion. ACCESS is a registered trademark or trademark of ACCESS CO., LTD. in the United States, Japan and/or other countries. Northforge Innovations is a registered trademark of Northforge Innovations, Inc. All other trademarks, service marks, registered trademarks, or registered service marks mentioned are the property of their respective owners.
-end-
Media Contact:
Katherine Verducci
1903 PR
kverducci@1903pr.com
408.429.5779
Chi è IP Infusion
IP Infusion è un fornitore leader di software di open networking e offre OcNOS, un sistema operativo di rete carrier-grade per service provider, data center e reti fabric AI. Con esperienza nel networking dal 1999 e oltre 600 operatori nel mondo, IP Infusion abilita un'infrastruttura di rete aperta, multi-vendor, efficiente nei costi e flessibile su hardware aperto validato di partner come Edgecore Networks, UfiSpace e Celestica. IP Infusion è una controllata al 100% di ACCESS CO., LTD. (Borsa di Tokyo: 4813).
Contatto stampa
For press inquiries, analyst briefings, or media materials, please contatti il nostro team or email pr@ipinfusion.com.
Dichiarazioni previsionali
Questo comunicato può contenere dichiarazioni previsionali relative a prodotti, tecnologie e piani di IP Infusion. Le dichiarazioni previsionali si basano sulle informazioni disponibili alla data di pubblicazione e comportano rischi e incertezze. I risultati effettivi possono differire. Piani di prodotto, funzionalità, tempistiche di rilascio e disponibilità sono soggetti a modifiche senza preavviso e non costituiscono un impegno, una promessa o un obbligo legale. IP Infusion non assume alcun obbligo di aggiornare le dichiarazioni previsionali.